Sandu Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 764862, "name": "Sandu Pharma.", "stock_name": "Sandu Pharma.", "full_name": "Sandu Pharmaceuticals Ltd", "name_url": "stocks-analysis/sandu-pharma", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "42.59", "chg": -0.45, "chgp": "-1.05%", "dir": -1, "prev_price": "43.04", "mcapval": "42.00 Cr", "mcap": "Micro Cap", "scripcode": 524703, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 49, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE751D01014", "curr_date": "Jun 03, 03:30 PM", "curr_time": "00:21 AM", "last_traded_at": "Jun 03, 03:30 PM IST", "bse_nse_vol": "1.16 k", "exc_status": "Active", "traded_date": "Jun 03, 2026", "traded_date_str": "2026 06 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sandu-pharma-764862-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Sandu Pharmaceuticals Ltd Upgraded to Sell on Technical and Valuation Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-upgraded-to-sell-on-technical-and-valuation-improvements-4030077", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SanduPharmaceut_mojoScore_4030077.png", "date": "2026-06-02 08:27:52", "description": "Sandu Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 June 2026, reflecting notable improvements in its technical outlook and valuation metrics despite ongoing fundamental challenges. The micro-cap pharmaceutical company’s Mojo Score rose to 37.0, signalling a cautious but more optimistic stance among analysts." }, { "title": "Sandu Pharmaceuticals Gains 7.69%: 2 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-gains-769-2-key-factors-driving-the-weeks-volatility-4023153", "imagepath": "", "date": "2026-05-30 15:05:00", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Stock opens at Rs.39.96, gaining 2.46%</p>\n <p><strong>26 May:</strong> Sharp rally of 10.46% to Rs.44.14 despite downgrade</p>\n <p><strong>27 May:</strong> Downgrade to Strong Sell announced; price steady at Rs.44.13</p>\n <p><strong>29 May:</strong> Week closes at Rs.42.00, down 4.83% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.39.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.42.00</div><..." }, { "title": "Sandu Pharmaceuticals Downgraded to Strong Sell Amid Mixed Valuation and Weak Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-downgraded-to-strong-sell-amid-mixed-valuation-and-weak-fundamentals-4015911", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanduPharmaceut_mojoScore_4015911.png", "date": "2026-05-27 08:07:38", "description": "Sandu Pharmaceuticals Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 26 May 2026, reflecting a complex interplay of valuation improvements offset by deteriorating financial trends and weak quality metrics. Despite an attractive valuation profile, the company’s long-term fundamentals and technical outlook remain concerning, prompting a cautious stance from analysts." }, { "title": "Sandu Pharmaceuticals Ltd Valuation Shifts Signal Changing Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-ltd-valuation-shifts-signal-changing-market-sentiment-4015589", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanduPharmaceut_valuationdot_4015589.png", "date": "2026-05-27 08:01:05", "description": "Sandu Pharmaceuticals Ltd has seen a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a challenging market backdrop and a recent upgrade to a Strong Sell Mojo Grade. This article analyses the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios in comparison to historical averages and peer benchmarks, providing a comprehensive view of its price attractiveness and investment potential." }, { "title": "Sandu Pharmaceuticals Declines 2.37% Despite Valuation Upgrade: 2 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-declines-237-despite-valuation-upgrade-2-key-factors-driving-the-week-3994562", "imagepath": "", "date": "2026-05-16 15:08:59", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>11 May:</strong> Stock opens at Rs.39.02, down 0.76% as Sensex falls 1.40%</p>\n <p><strong>12 May:</strong> Continued decline to Rs.38.46 amid broader market weakness</p>\n <p><strong>13 May:</strong> Stock hits weekly low of Rs.37.48 following valuation upgrade announcement</p>\n <p><strong>14 May:</strong> MarketsMOJO upgrades rating to Sell on improved valuation metrics</p>\n <p><strong>15 May:</strong> Stock rebounds to Rs.38.39 despite Sensex retreat</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div c..." }, { "title": "Sandu Pharmaceuticals Ltd Upgraded to Sell on Improved Valuation Metrics", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-upgraded-to-sell-on-improved-valuation-metrics-3990572", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanduPharmaceut_mojoScore_3990572.png", "date": "2026-05-14 08:10:05", "description": "Sandu Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a marked improvement in its valuation metrics despite ongoing challenges in financial performance and technical indicators. This nuanced shift reflects a more attractive entry point for investors, even as the company continues to face headwinds in growth and profitability." }, { "title": "Sandu Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-3990336", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanduPharmaceut_valuationdot_3990336.png", "date": "2026-05-14 08:00:43", "description": "Sandu Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to a very attractive rating despite recent share price declines and a challenging market backdrop. This article analyses the company’s updated price-to-earnings (P/E) and price-to-book value (P/BV) ratios in comparison to historical levels and peer benchmarks, providing investors with a comprehensive view of its current price attractiveness." }, { "title": "Sandu Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-strong-sell-3987314", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanduPharmaceut_mojoScore_3987314.png", "date": "2026-05-12 10:10:46", "description": "Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Sep 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "When is the next results date for Sandu Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sandu-pharmaceuticals-ltd-3967217", "imagepath": "", "date": "2026-04-28 23:16:14", "description": "The next results date for Sandu Pharmaceuticals Ltd is scheduled for 05 May 2026...." } ], "total": 104, "sid": "764862", "stock_news_url": "https://www.marketsmojo.com/news/sandu-pharmaceuticals-764862" }, "announcements": [ { "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance", "datetime": "18-May-2026", "details": "Annual Secretarial Compliance Report for Year ended 31st March 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "07-May-2026", "details": "Newspaper Publication for Audited Financials for the Q and Year ended 31.03.2026", "source": "BSE" }, { "caption": "Announcement Under Regulation 30-Update Demand Order From Office Of Assistant Commissioner Jurisdiction Sector 3 (Mobile Squad-1) Shamli State/UT Uttar Pradesh For Detention Of Conveyance & Goods Due To Discrepancy In Quantity As Per Invoice & Quantity As", "datetime": "07-May-2026", "details": "Demand order from office of assistant commissioner due to discrepancy in quantity as per invoice and quantity as per physical verification of Goods", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Sandu Pharmaceuticals Ltd has declared <strong>8%</strong> dividend, ex-date: 18 Sep 25", "dt": "2025-09-18", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

11 May: Stock opens at Rs.39.02, down 0.76% as Sensex falls 1.40%

12 May: Continued decline to Rs.38.46 amid broader market weakness

13 May: Stock hits weekly low of Rs.37.48 following valuation upgrade announcement

14 May: MarketsMOJO upgrades rating to Sell on improved valuation metrics

15 May: Stock rebounds to Rs.38.39 despite Sensex retreat

Week Open

Read full news article

Sandu Pharmaceuticals Ltd Upgraded to Sell on Improved Valuation Metrics

2026-05-14 08:10:05

Sandu Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a marked improvement in its valuation metrics despite ongoing challenges in financial performance and technical indicators. This nuanced shift reflects a more attractive entry point for investors, even as the company continues to face headwinds in growth and profitability.

Read full news article

Sandu Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-05-14 08:00:43

Sandu Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to a very attractive rating despite recent share price declines and a challenging market backdrop. This article analyses the company’s updated price-to-earnings (P/E) and price-to-book value (P/BV) ratios in comparison to historical levels and peer benchmarks, providing investors with a comprehensive view of its current price attractiveness.

Read full news article

Sandu Pharmaceuticals Ltd is Rated Strong Sell

2026-05-12 10:10:46

Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Sep 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

When is the next results date for Sandu Pharmaceuticals Ltd?

2026-04-28 23:16:14

The next results date for Sandu Pharmaceuticals Ltd is scheduled for 05 May 2026....

Read full news article